Skip to main content
# Title Department Research Year
111 Synthesis new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
112 Tetrahydrocarbazoles incorporating 5-arylidene-4-thiazolinones as potential antileukemia and antilymphoma targeting tyrosine kinase and tubulin polymerase enzymes: Design, synthesis, structural, biological and molecular docking studies Department of Pharmaceutical Organic Chemistry 2024
113 Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability Department of Clinical Pharmacy 2024
114 New series of 4, 6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
115 First electrochemical nanosensor for ultrasensitive quantification of MET inhibitor, capmatinib based on carbon nanofiber networks incorporated with hybrid nanofiller nanogold-loaded porous acetylene black Department of Pharmaceutical Analytical Chemistry 2024
116 Comparative study of Lepidium sativum orally administered seeds, hydrogel and atorvastatin on obesity of rats fed on a high fat diet Department of Industrial Pharmacy 2024
117 Dual-Modulation ratiometric fluorescence strategy for cobalt and topotecan detection using Red-Emissive carbon dots Department of Pharmaceutical Analytical Chemistry 2024
118 Computational Design of Azine-Linked Hybrids of 2-Indolinone-Thiazolodine Scaffold as Novel and Promising Quorum Sensing Inhibitors Department of Medicinal Chemistry 2024
119 Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives Department of Pharmaceutical Organic Chemistry 2024
120 Curcumin-loaded gold nanoparticles with enhanced antibacterial efficacy and wound healing properties in diabetic rats Department of Pharmaceutics 2024